| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,716 |
31,644 |
$3.27M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,382 |
12,587 |
$1.39M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,406 |
6,082 |
$1.10M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,191 |
1,916 |
$857K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,689 |
5,349 |
$677K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,818 |
4,537 |
$632K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,328 |
9,298 |
$624K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,418 |
2,166 |
$614K |
| 36415 |
Collection of venous blood by venipuncture |
12,714 |
9,781 |
$579K |
| 80053 |
Comprehensive metabolic panel |
20,041 |
17,822 |
$572K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,225 |
2,118 |
$428K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,729 |
6,993 |
$370K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,203 |
2,595 |
$313K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,044 |
1,981 |
$286K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,142 |
1,120 |
$267K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,581 |
1,489 |
$251K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
899 |
866 |
$239K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,843 |
1,353 |
$225K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
218 |
218 |
$224K |
| 70450 |
Computed tomography, head or brain; without contrast material |
769 |
751 |
$223K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,189 |
2,136 |
$209K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,028 |
1,368 |
$195K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
7,054 |
1,986 |
$194K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,947 |
1,082 |
$193K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,682 |
1,556 |
$184K |
| 90837 |
Psychotherapy, 53 minutes with patient |
801 |
506 |
$167K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,101 |
2,607 |
$149K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,427 |
1,411 |
$143K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,313 |
4,295 |
$129K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,530 |
7,657 |
$128K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,317 |
1,300 |
$128K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,502 |
1,312 |
$127K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,461 |
3,069 |
$120K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
641 |
553 |
$112K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,099 |
1,094 |
$107K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,518 |
1,515 |
$104K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,109 |
1,103 |
$101K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,197 |
1,153 |
$100K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,013 |
1,010 |
$100K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,414 |
1,386 |
$92K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,175 |
1,372 |
$82K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,176 |
2,116 |
$77K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
877 |
821 |
$77K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
638 |
637 |
$75K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
450 |
448 |
$74K |
| 90791 |
Psychiatric diagnostic evaluation |
446 |
381 |
$72K |
| 80061 |
Lipid panel |
8,348 |
8,295 |
$70K |
| 80050 |
General health panel |
1,212 |
1,140 |
$70K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,157 |
1,133 |
$66K |
| 90686 |
|
2,097 |
2,087 |
$65K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,129 |
1,964 |
$61K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,952 |
7,810 |
$57K |
| 87486 |
|
977 |
950 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,032 |
18,625 |
$45K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
298 |
284 |
$42K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
53 |
52 |
$38K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,442 |
1,423 |
$38K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
858 |
812 |
$37K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
293 |
190 |
$34K |
| 97162 |
|
308 |
308 |
$33K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
251 |
243 |
$32K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,378 |
5,337 |
$30K |
| 99215 |
Prolong outpt/office vis |
191 |
165 |
$29K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
206 |
205 |
$28K |
| 99401 |
|
885 |
753 |
$27K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,465 |
1,452 |
$27K |
| 99442 |
|
263 |
237 |
$25K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,411 |
307 |
$24K |
| 82728 |
|
2,346 |
2,303 |
$23K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,762 |
3,554 |
$23K |
| 88142 |
|
1,021 |
1,019 |
$23K |
| 84439 |
|
3,150 |
3,119 |
$22K |
| 99406 |
|
733 |
703 |
$21K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,038 |
1,615 |
$21K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
68 |
67 |
$21K |
| 82607 |
|
2,002 |
1,988 |
$20K |
| 90836 |
|
240 |
215 |
$19K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$19K |
| S5161 |
Emergency response system; service fee, per month (excludes installation and testing) |
1,748 |
1,689 |
$19K |
| 87581 |
|
977 |
950 |
$19K |
| 90715 |
|
604 |
601 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
146 |
145 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
839 |
831 |
$17K |
| 87088 |
|
3,917 |
3,678 |
$16K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
787 |
775 |
$15K |
| 90670 |
|
591 |
588 |
$15K |
| 76830 |
Ultrasound, transvaginal |
361 |
350 |
$14K |
| 71250 |
|
179 |
179 |
$13K |
| 84153 |
|
948 |
938 |
$13K |
| 86703 |
|
915 |
910 |
$13K |
| 11043 |
|
123 |
55 |
$13K |
| 81001 |
|
7,787 |
7,370 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
2,549 |
2,481 |
$12K |
| 90648 |
|
599 |
596 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
66 |
66 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,538 |
2,415 |
$11K |
| 83655 |
|
639 |
637 |
$10K |
| 94060 |
|
108 |
108 |
$10K |
| 83540 |
|
2,839 |
2,801 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,369 |
1,365 |
$10K |
| 83550 |
|
2,839 |
2,800 |
$10K |
| 82803 |
|
245 |
239 |
$9K |
| 99441 |
|
73 |
65 |
$8K |
| 73564 |
|
849 |
809 |
$8K |
| 90633 |
|
387 |
386 |
$8K |
| 86850 |
|
187 |
180 |
$8K |
| 90651 |
|
144 |
144 |
$8K |
| 93000 |
|
1,649 |
1,572 |
$7K |
| 82043 |
|
1,888 |
1,852 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,619 |
2,293 |
$7K |
| 59025 |
Fetal non-stress test |
90 |
52 |
$6K |
| 90734 |
|
240 |
239 |
$6K |
| 87076 |
|
1,643 |
1,572 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,498 |
2,471 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
319 |
166 |
$6K |
| 84703 |
|
2,803 |
2,653 |
$6K |
| 84702 |
|
595 |
453 |
$6K |
| 90723 |
|
341 |
339 |
$5K |
| 85610 |
|
1,941 |
1,631 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
652 |
587 |
$5K |
| 86803 |
|
684 |
670 |
$5K |
| 83735 |
|
1,815 |
1,412 |
$5K |
| 87186 |
|
1,644 |
1,573 |
$5K |
| 86900 |
|
257 |
248 |
$3K |
| 99443 |
|
39 |
38 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
27 |
27 |
$3K |
| 83020 |
|
272 |
269 |
$3K |
| 99205 |
Prolong outpt/office vis |
14 |
14 |
$3K |
| 81015 |
|
4,456 |
3,386 |
$3K |
| 99188 |
|
42 |
42 |
$3K |
| 86140 |
|
1,079 |
993 |
$3K |
| 36591 |
|
86 |
54 |
$3K |
| 86141 |
|
411 |
375 |
$3K |
| 87070 |
|
709 |
675 |
$2K |
| 76641 |
|
81 |
69 |
$2K |
| J3490 |
Unclassified drugs |
350 |
292 |
$2K |
| 86901 |
|
187 |
180 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
79 |
76 |
$2K |
| 86618 |
|
176 |
165 |
$2K |
| 86580 |
|
84 |
76 |
$2K |
| 85652 |
|
1,171 |
1,110 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,249 |
1,199 |
$2K |
| 72110 |
|
131 |
131 |
$2K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
18 |
17 |
$2K |
| 90461 |
|
1,100 |
1,090 |
$2K |
| 90707 |
|
90 |
89 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
52 |
52 |
$2K |
| G0378 |
Hospital observation service, per hour |
23 |
12 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,157 |
1,776 |
$2K |
| 73030 |
|
232 |
221 |
$2K |
| 82746 |
|
153 |
150 |
$2K |
| 80076 |
|
229 |
219 |
$1K |
| 85730 |
|
1,163 |
1,111 |
$1K |
| 90681 |
|
84 |
83 |
$1K |
| 97161 |
|
13 |
13 |
$1K |
| 87481 |
|
70 |
69 |
$1K |
| 73630 |
|
311 |
300 |
$1K |
| 82784 |
|
112 |
110 |
$1K |
| 84484 |
|
1,859 |
1,661 |
$1K |
| 90716 |
|
54 |
54 |
$1K |
| 86038 |
|
226 |
223 |
$1K |
| 83690 |
|
1,943 |
1,808 |
$1K |
| 96367 |
|
32 |
25 |
$1K |
| 71271 |
|
51 |
51 |
$920.96 |
| 73610 |
|
234 |
225 |
$894.27 |
| 86780 |
|
86 |
84 |
$848.69 |
| 94726 |
|
40 |
40 |
$843.28 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,460 |
1,431 |
$842.11 |
| 85014 |
|
295 |
285 |
$817.42 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
65 |
$769.75 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,081 |
661 |
$617.74 |
| 82550 |
|
1,091 |
1,026 |
$600.84 |
| 81002 |
|
956 |
918 |
$586.21 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
578 |
254 |
$505.56 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
13 |
13 |
$481.55 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
352 |
321 |
$467.43 |
| 84480 |
|
77 |
77 |
$441.67 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
175 |
161 |
$422.52 |
| 94729 |
|
40 |
40 |
$340.25 |
| J2704 |
Injection, propofol, 10 mg |
590 |
543 |
$334.10 |
| 84100 |
|
107 |
87 |
$326.18 |
| 85379 |
|
205 |
202 |
$305.86 |
| 90696 |
|
17 |
17 |
$303.45 |
| 83519 |
|
140 |
133 |
$297.63 |
| 86430 |
|
77 |
76 |
$293.94 |
| 87634 |
|
129 |
128 |
$275.49 |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
21 |
21 |
$275.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
793 |
651 |
$247.40 |
| 93017 |
|
12 |
12 |
$210.00 |
| 74018 |
|
42 |
42 |
$208.80 |
| 86376 |
|
12 |
12 |
$203.70 |
| 83605 |
|
476 |
443 |
$184.50 |
| 73110 |
|
62 |
61 |
$179.22 |
| 73502 |
|
29 |
26 |
$157.47 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
425 |
348 |
$153.67 |
| 87040 |
|
260 |
246 |
$143.74 |
| 82553 |
|
537 |
509 |
$133.03 |
| 94761 |
|
848 |
811 |
$130.79 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,757 |
1,586 |
$130.35 |
| 87650 |
|
380 |
378 |
$128.52 |
| 86329 |
|
12 |
12 |
$128.35 |
| 82785 |
|
13 |
13 |
$124.27 |
| 82565 |
|
25 |
25 |
$111.81 |
| 86617 |
|
19 |
19 |
$107.15 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
258 |
240 |
$96.59 |
| 82150 |
|
162 |
159 |
$92.81 |
| 73130 |
|
65 |
61 |
$87.58 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
996 |
913 |
$84.93 |
| 82787 |
|
12 |
12 |
$68.94 |
| 82947 |
|
22 |
12 |
$43.03 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
25 |
24 |
$42.80 |
| 82977 |
|
12 |
12 |
$40.24 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
320 |
286 |
$39.16 |
| 83615 |
|
18 |
13 |
$38.49 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14 |
14 |
$33.10 |
| 82948 |
|
114 |
77 |
$31.41 |
| J1450 |
Injection fluconazole, 200 mg |
86 |
66 |
$23.92 |
| J1756 |
Injection, iron sucrose, 1 mg |
60 |
24 |
$21.27 |
| J7050 |
Infusion, normal saline solution, 250 cc |
49 |
47 |
$15.10 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
468 |
461 |
$13.62 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
183 |
145 |
$10.50 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
71 |
69 |
$9.34 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
220 |
212 |
$1.54 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
27 |
24 |
$1.50 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
332 |
332 |
$0.01 |
| 99173 |
|
17 |
17 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
33 |
32 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
14 |
$0.00 |
| 88300 |
|
61 |
61 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
31 |
27 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
35 |
34 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
14 |
12 |
$0.00 |